Combination CAR-T Cell Therapy Targeting Hematological Malignancies

This trial is testing a new approach using specially engineered immune cells (called CAR-T cells) that are designed to attack several different proteins found on blood cancer cells at the same time. **You may be eligible if...** - You are older than 6 months - You have a blood cancer involving B cells that carry certain proteins on the surface (CD19, CD20, CD22, CD30, CD38, CD70, or CD123) - Your general health is reasonably good (KPS score over 80) and you are expected to live more than one month - Your hemoglobin level is above 80 g/L - You have no medical reason that prevents blood cell collection **You may NOT be eligible if...** - You have another active serious illness that would make it hard to judge how the treatment is working - You have an uncontrolled bacterial, fungal, or viral infection - You are living with HIV Talk to your doctor to see if this trial is right for you.